NCPC(SH:600812) 智通财经网·2025-11-04 09:07Core Viewpoint - Huabei Pharmaceutical's subsidiary, Hebei Huamin Pharmaceutical Co., has received approval from the National Medical Products Administration for the marketing application of Cefotolan Pivoxil, a third-generation cephalosporin antibiotic [1] Group 1: Product Details - Cefotolan Pivoxil is a third-generation cephalosporin antibiotic that is hydrolyzed into the active form Cefotolan after absorption, exhibiting antibacterial properties [1] - The antibiotic shows significant effectiveness against five major pathogens causing community-acquired respiratory infections, particularly against penicillin-resistant Streptococcus pneumoniae and Staphylococcus aureus [1] Group 2: Indications - The product is indicated for infections caused by sensitive bacteria, including superficial and deep skin infections, lymphangitis, chronic pyoderma, and secondary infections from trauma, burns, and surgical wounds [1] - Additional indications include perianal abscess, pharyngitis, laryngitis, tonsillitis (including peritonsillar abscess), acute bronchitis, pneumonia, lung abscess, chronic respiratory infections, otitis media, sinusitis, periodontitis, jaw inflammation, cystitis, pyelonephritis, scarlet fever, and whooping cough [1]